|
Market Closed -
NYSE
21:03:20 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 92.07 USD | +0.99% |
|
-1.88% | +18.98% |
| 09-01 | Wells Fargo Adjusts Price Target on Ventas to $104 From $96, Maintains Overweight Rating | MT |
| 08-31 | Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Healthcare REITs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 46.77B | |||||
| 170B | |||||
| 14.36B | |||||
| 13.85B | |||||
| 12.77B | |||||
| 9.2B |
- Stock Market
- Stocks
- VTR Stock
- Charts Ventas, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
